PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Some harmful effects of light at night can be reversed

2012-07-25
(Press-News.org) COLUMBUS, Ohio -- Chronic exposure to dim light at night can lead to depressive symptoms in rodents -- but these negative effects can be reversed simply by returning to a standard light-dark cycle, a new study suggests.

While hamsters exposed to light at night for four weeks showed evidence of depressive symptoms, those symptoms essentially disappeared after about two weeks if they returned to normal lighting conditions.

Even changes in the brain that occurred after hamsters lived with chronic light at night reversed themselves after returning to a more normal light cycle.

These findings add to the growing evidence that suggest chronic exposure to artificial light at night may play some role in the rising rates of depression in humans during the past 50 years, said Tracy Bedrosian, lead author of the study and doctoral student in neuroscience at Ohio State University.

"The results we found in hamsters are consistent with what we know about depression in humans," Bedrosian said.

But the new study, published online in the journal Molecular Psychiatry, also offers some hope.

"The good news is that people who stay up late in front of the television and computer may be able to undo some of the harmful effects just by going back to a regular light-dark cycle and minimizing their exposure to artificial light at night," Bedrosian said. "That's what the results we found in hamsters would suggest."

Bedrosian conducted the study with Ohio State colleagues Randy Nelson, professor of neuroscience and psychology, and Zachary Weil, research assistant professor in neuroscience.

This study is the latest in a series out of Nelson's lab that have linked chronic exposure to light at night to depression and obesity in animal models.

The new study found that one particular protein found in the brain of hamsters -- and humans -- may play a key role in how light at night leads to depression.

They found that blocking effects of that protein, called tumor necrosis factor, prevented the development of depressive-like symptoms in hamsters even when they were exposed to light at night.

The study involved two experiments using female Siberian hamsters, which had their ovaries removed to ensure that hormones produced in the ovary would not interfere with the results.

In the first experiment, half of the hamsters spent eight weeks in a standard light-dark cycle of 16 hours of light (150 lux) and 8 hours of total darkness each day. The other half spent the first four weeks with 16 hours of normal daylight (150 lux) and 8 hours of dim light -- 5 lux, or the equivalent of having a television on in a darkened room.

Then, these hamsters were moved back to a standard light cycle for either one week, two weeks or four weeks before testing began.

They were then given a variety of behavior tests. Results showed that hamsters exposed to chronic dim light at night showed less total activity during their active period each day when compared to those in standard lighting conditions.

Those hamsters exposed to dim light also showed greater depressive symptoms than did the others-- such as less interest in drinking sugar water that they usually enjoy.

But within two weeks of returning to a standard light cycle, hamsters exposed to dim night light showed no more depressive-like symptoms than did hamsters that always had standard lighting. In addition, they returned to normal activity levels.

After the behavioral testing, the hamsters were sacrificed and the researchers studied a part of their brains called the hippocampus, which plays a key role in depressive disorders. Findings showed that hamsters exposed to dim light showed a variety of changes associated with depression.

Most importantly, hamsters that lived in dim light showed increased expression of the gene that produces tumor necrosis factor. TNF is one of a large family of proteins called cytokines -- chemical messengers that are mobilized when the body is injured or has an infection. These cytokines cause inflammation in their effort to repair an injured or infected area of the body. However, this inflammation can be damaging when it is constant, as happens in hamsters exposed to dim light at night.

"Researchers have found a strong association in people between chronic inflammation and depression," said Nelson, who is a member of Ohio State's Institute for Behavioral Medicine Research.

"That's why it is very significant that we found this relationship between dim light at night and increased expression of TNF."

In addition, results showed that hamsters that lived in dim light had a significantly reduced density of dendritic spines -- hairlike growths on brain cells which are used to send chemical messages from one cell to another.

Changes such as this have been linked to depression, Bedrosian said.

However, hamsters that were returned to a standard light-dark cycle after four weeks of dim light at night saw their TNF levels and even their density of dendritic spines return essentially to normal.

"Changes in dendritic spines can happen very rapidly in response to environmental factors," Bedrosian said.

In a second experiment, the researchers tested just how important TNF might be in causing the negative effects seen in hamsters exposed to light at night. In this experiment, some hamsters were given a drug called XPro1595, which is a TNF inhibitor -- meaning that it negates the effects of some forms of TNF in the brain.

Results showed that hamsters exposed to dim light at night did not show any more depressive-like symptoms than standard-light hamsters if they were given XPro1595. However, the drug did not seem to prevent the reduction of dendritic spine density in hamsters exposed to dim light.

These results provide further evidence of the role TNF may play in the depressive symptoms seen in hamsters exposed to dim light. But the fact that XPro1595 did not affect dendritic spine density means that more needs to be learned about exactly how TNF works, Nelson said.

###

The study was supported by grants from the National Science Foundation and the U.S. Department of Defense. The XPro1595 used in the study was provided by Xencor, Inc.

Contact: Tracy Bedrosian, Bedrosian.2@osu.edu
Randy Nelson, Randy.Nelson@osumc.edu

(It is best to reach both researchers first by email.)

Written by Jeff Grabmeier, (614) 292-8457; Grabmeier.1@osu.edu

END



ELSE PRESS RELEASES FROM THIS DATE:

A quarter of our very elderly have undiagnosed treatable heart problems, research reveals

2012-07-25
The very oldest in our society are missing out on simple heart treatments which can prolong and improve their quality of life, Newcastle heart experts say. Studying a group of people aged 87 to 89 years old, the team of researchers at Newcastle University found that a routine test in the home revealed that around a quarter of them had undiagnosed heart problems which could be treated with established and cost-effective treatments. In the study, funded by the British Heart Foundation (BHF), the team visited the homes of 376 people aged 87 to 89 years old and carried ...

Physicists study the classics for hidden truths

2012-07-25
The truth behind some of the world's most famous historical myths, including Homer's epic, the Iliad, has been bolstered by two researchers who have analysed the relationships between the myths' characters and compared them to real-life social networks. In a study published online today, 25 July, in the journal EPL (Europhysics Letters), Pádraig Mac Carron and Ralph Kenna from Coventry University performed detailed text analyses of the Iliad, the English poem, Beowulf, and the Irish epic, the Táin Bó Cuailnge. They found that the interactions between the characters ...

Lace plants explain programmed cell death

2012-07-25
Programmed cell death (PCD) is a highly regulated process that occurs in all animals and plants as part of normal development and in response to the environment. New research published in BioMed Central's open access journal BMC Plant Biology is the first to document the physiological events in the lace plant (Aponogeton madagascariensis) which occur via PCD to produce the characteristic holes in its leaves. The aquatic lace plant, endemic to Madagascar, uses PCD to generate holes in its leaves. Researchers from Dalhousie University, Nova Scotia, used long-term live ...

Use of sunbeds leads to 3000+ cases of melanoma a year in Europe and 'tougher actions' are needed

2012-07-25
Of 63,942 new cases of cutaneous melanoma (a form of skin cancer) diagnosed each year in Europe an estimated 3,438 (5.4%) are related to sunbed use. Sunbed users are at a 20% increased relative risk of skin cancer compared with those who have never used a sunbed. This risk doubles if they start before the age of 35 and experts warn that "tougher actions" are needed to reduce this risk. Sun exposure is the most significant environmental cause of skin cancer and sunbeds have become the main non-solar source of UV exposure in Western Europe (UV is the wavelength associated ...

Concerns over accuracy of tools to predict risk of repeat offending

2012-07-25
Research: Use of risk assessment instruments to predict violence and antisocial behaviour in 73 samples involving 24,827 people: systematic review and meta-analysis Tools designed to predict an individual's risk of repeat offending are not sufficient on their own to inform sentencing and release or discharge decisions, concludes a study published on bmj.com today. Although they appear to identify low risk individuals with high levels of accuracy, the authors say "their use as sole determinants of detention, sentencing, and release is not supported by the current evidence." Risk ...

Study reveals substantial misdiagnosis of malaria in parts of Asia

2012-07-25
Research: Overdiagnosis and mistreatment of malaria among febrile patients at primary healthcare level in Afghanistan: observational study Substantial overdiagnosis and mistreatment of malaria is evident in south and central Asia, warns a study published on bmj.com today. With more than two billion people at risk of malaria in this part of Asia – larger than that of Africa - this is a major public health problem which needs to be confronted, say the authors. Malaria remains one of the most important infectious diseases of poverty. Recent global malaria treatment ...

New drug could treat Alzheimer's, multiple sclerosis and brain injury

2012-07-25
CHICAGO --- A new class of drug developed at Northwestern University Feinberg School of Medicine shows early promise of being a one-size-fits-all therapy for Alzheimer's disease, Parkinson's disease, multiple sclerosis and traumatic brain injury by reducing inflammation in the brain. Northwestern has recently been issued patents to cover this new drug class and has licensed the commercial development to a biotech company that has recently completed the first human Phase 1 clinical trial for the drug. The drugs in this class target a particular type of brain inflammation, ...

New research determines how a single brain trauma may lead to Alzheimer's disease

2012-07-25
BOSTON (July 24, 2012, 5:00PM EST)—A study, performed in mice and utilizing post-mortem samples of brains from patients with Alzheimer's disease, found that a single event of a moderate-to-severe traumatic brain injury (TBI) can disrupt proteins that regulate an enzyme associated with Alzheimer's. The paper, published in The Journal of Neuroscience, identifies the complex mechanisms that result in a rapid and robust post-injury elevation of the enzyme, BACE1, in the brain. These results may lead to the development of a drug treatment that targets this mechanism to slow ...

New publication examines effect of early drug administration on Alzheimer's animal model

2012-07-25
LEXINGTON, Ky. (July 25, 2012) — In a study published June 25 in the Journal of Neuroscience, a collaborative team of researchers led by Linda J. Van Eldik, director of the University of Kentucky Sanders-Brown Center on Aging, and D. Martin Watterson of the Northwestern University Feinberg School of Medicine, present results showing that a new central nervous system drug compound can reduce Alzheimer's pathology in a mouse model of the disease. The drug, called MW-151, is a selective suppressor of brain inflammation and overproduction of proinflammatory molecules from glial ...

EARTH: 2012

2012-07-25
Alexandria, VA – December 21, 2012 – the purported last day of a 5,125-year cycle in the Mesoamerican calendar – has been added to an endless list of days when the world has been expected to end. But what are our real chances of being wiped out by a catastrophic event – the kind that has happened in the past and will inevitably occur again someday? In the August issue of EARTH, we explore four of the most probable global events that could change life on Earth forever. Near-Earth objects (NEOs), super-eruptions, solar storms and cataclysmic earthquakes all pose serious ...

LAST 30 PRESS RELEASES:

We could soon use AI to detect brain tumors

TAMEST recognizes Lyda Hill and Lyda Hill Philanthropies with Kay Bailey Hutchison Distinguished Service Award

Establishment of an immortalized red river hog blood-derived macrophage cell line

Neural networks: You might not need to buy every ticket to win the lottery

Healthy New Town: Revitalizing neighborhoods in the wake of aging populations

High exposure to everyday chemicals linked to asthma risk in children

How can brands address growing consumer scepticism?

New paradigm of quantum information technology revealed through light-matter interaction!

MSU researchers find trees acclimate to changing temperatures

World's first visual grading system developed to combat microplastic fashion pollution

Teenage truancy rates rise in English-speaking countries

Cholesterol is not the only lipid involved in trans fat-driven cardiovascular disease

Study: How can low-dose ketamine, a ‘lifesaving’ drug for major depression, alleviate symptoms within hours? UB research reveals how

New nasal vaccine shows promise in curbing whooping cough spread

Smarter blood tests from MSU researchers deliver faster diagnoses, improved outcomes

Q&A: A new medical AI model can help spot systemic disease by looking at a range of image types

For low-risk pregnancies, planned home births just as safe as birth center births, study shows

Leaner large language models could enable efficient local use on phones and laptops

‘Map of Life’ team wins $2 million prize for innovative rainforest tracking

Rise in pancreatic cancer cases among young adults may be overdiagnosis

New study: Short-lived soda tax reinforces alternative presumptions on tax impacts on consumer behaviors

Fewer than 1 in 5 know the 988 suicide lifeline

Semaglutide eligibility across all current indications for US adults

Can podcasts create healthier habits?

Zerlasiran—A small-interfering RNA targeting lipoprotein(a)

Anti-obesity drugs, lifestyle interventions show cardiovascular benefits beyond weight loss

Oral muvalaplin for lowering of lipoprotein(a)

Revealing the hidden costs of what we eat

New therapies at Kennedy Krieger offer effective treatment for managing Tourette syndrome

American soil losing more nutrients for crops due to heavier rainstorms, study shows

[Press-News.org] Some harmful effects of light at night can be reversed